Radiotherapy in Hodgkin's Lymphoma Treatment
Hours: 1.00
Radiotherapy is one of the primary interventions used to limit the progress of Hodgkin’s lymphoma (HL). Traditionally, chemotherapy with or without radiotherapy has been used to improve survival in patients. The decision to include radiotherapy in the treatment protocol for HL usually depends on the severity of the cancer at the time of diagnosis. Recently, studies following HL survivors for a longer duration after remission have found an increased occurrence of secondary malignant neoplasms and cardiovascular diseases. Such adverse effects lower the quality of life in surviving patients. Radiotherapeutic intervention in patients with HL should be implemented only after careful examination of patient parameters that necessitate this treatment strategy. Knowledge of risks and benefits of this intervention is helpful for recommending effective treatment plans.
Radiotherapy is one of the primary interventions used to limit the progress of Hodgkin’s lymphoma (HL). Traditionally, chemotherapy with or without radiotherapy has been used to improve survival in patients. The decision to include radiotherapy in the treatment protocol for HL usually depends on the severity of the cancer at the time of diagnosis. Recently, studies following HL survivors for a longer duration after remission have found an increased occurrence of secondary malignant neoplasms and cardiovascular diseases. Such adverse effects lower the quality of life in surviving patients. Radiotherapeutic intervention in patients with HL should be implemented only after careful examination of patient parameters that necessitate this treatment strategy. Knowledge of risks and benefits of this intervention is helpful for recommending effective treatment plans.
